Goldman Sachs Remains Bullish on Petco (WOOF) With $3.95 Price Target

2 hours ago 1

Jordan Chussler

Fri, March 13, 2026 astatine 10:52 AM CDT 3 min read

  • Most Wall Street analysts transportation a statement terms people of conscionable $3.42, with 8 of 12 analysts standing the banal a Hold.

  • Goldman Sachs is taking a much assertive stance with a $3.95 terms people portion maintaining its Buy rating.

  • To get there, Petco volition person to instrumentality to affirmative comparable income arsenic guided, proceed EBITDA borderline enlargement and spot stabilization successful the broader user environment.

  • The expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks. Get them present FREE.

Petco Health & Wellness (NASDAQ:WOOF) has surged astir 48% implicit the past week and 37% implicit the past month, with shares present trading astir $3.44 arsenic of March 13. Year-to-date the banal is up much than 20%, though it remains good beneath its 52-week precocious of $4.50.

Most Wall Street analysts transportation a statement terms people of conscionable $3.42, with 8 of 12 analysts standing the banal a Hold. But Goldman Sachs is taking a much assertive stance. The steadfast maintained a Buy standing and issued a $3.95 terms people (lowered from $4.53), representing meaningful upside from the March 11 filing terms of $2.53. But tin WOOF realistically scope $3.95 by the extremity of 2026?

READ: The expert who called NVIDIA successful 2010 just named his apical 10 AI stocks

Goldman's condemnation rests connected Petco's Q4 adjusted EBITDA of $106.29M, which came successful supra some institution guidance and statement estimates. Adjusted EBITDA borderline expanded to 7.0% from 6.2% a twelvemonth ago, signaling that management's outgo restructuring is translating into durable profitability gains alternatively than one-time improvements. The steadfast views this arsenic grounds that the operational reset nether CEO Joel Anderson is connected track.

  1. EBITDA bushed and borderline expansion: Q4 adjusted EBITDA roseate 10.6% year-over-year with borderline betterment of 80 ground points to 7.0%. Q4 adjusted EBITDA roseate 10.6% year-over-year with borderline betterment of 80 ground points to 7.0%.

  2. Better-than-guided profitability: Full-year FY2026 adjusted EBITDA guidance of $415M-$430M reflects management's assurance successful sustaining gains. Free currency travel astir doubled year-over-year to $186.953M for the afloat year, providing a buffer to work indebtedness and reinvest without diluting shareholders.

  3. Improving operational execution: The leverage ratio improved sharply from 4.2x to 3.0x, reducing fiscal risk. Cash connected the equilibrium expanse grew 54.89% year-over-year to $256.736M, giving Petco flexibility that was absent conscionable a twelvemonth ago.

At 243.453 cardinal shares outstanding, a $3.95 terms people represents meaningful upside from the existent price. Getting determination requires 3 things: a instrumentality to affirmative comparable income arsenic guided, continued EBITDA borderline enlargement toward the $415M-$430M people range, and stabilization successful the broader user environment. University of Michigan user sentiment sits astatine a pessimistic 56.4, truthful Petco's comp betterment thesis depends connected sentiment betterment that is not yet confirmed.

Read Entire Article